Saturday 17 October 2026
Export PRVA’s income statement to Excel — free account
Privia Health Group, Inc.
PRVA Healthcare Health Information Services
Privia Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 22.3% from fiscal 2024. In the quarter to June 2026, revenue grew 21.4%, EPS grew 250.0% and free cash flow fell 86.2%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
22.46
0.16
−0.71%
Follow PRVA
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | 5 | 6 | 6 | 6 |
P/E ratio |
— | 70.42 | 70.42 | 70.42 | 0.00 | 0.00 | 124.79 | 150.38 | 131.72 |
Altman Z-Score |
— | — | — | — | 7.15 | 7.19 | 5.94 | 4.86 | 4.78 |
P/S ratio |
— | 2.70 | 2.70 | 2.70 | 2.76 | 1.82 | 1.67 | 1.34 | 1.36 |
Altman Z″-Score (non-manufacturers) |
— | — | — | 2.00 | 1.33 | 3.32 | 3.19 | 3.40 | 2.87 |
P/FCF ratio |
— | 51.21 | 51.21 | 51.21 | 48.86 | 52.40 | 34.38 | 21.42 | 17.76 |
Beneish M-Score |
— | — | — | — | (4.22) | (2.51) | (2.35) | (2.89) | (2.59) |
P/Operating CF |
— | (891.63) | (891.63) | (891.63) | (216.18) | 84.63 | 43.18 | 31.21 | 22.72 |
P/B ratio |
— | 14.78 | 14.78 | 14.78 | 5.92 | 4.75 | 4.56 | 3.42 | 3.66 |
Price to Tangible BV |
— | 88.71 | 88.71 | 88.71 | 10.15 | 7.37 | 7.67 | 5.40 | 7.93 |
EV/Sales |
— | 2.64 | 2.64 | 2.64 | 2.46 | 1.59 | 1.45 | 1.08 | 1.15 |
EV/EBITDA |
— | 74.73 | 74.73 | 74.73 | 0.00 | 0.00 | 88.65 | 77.31 | 55.47 |
EV/Operating CF |
— | 49.62 | 49.62 | 49.62 | 43.13 | 45.57 | 29.83 | 17.15 | 14.99 |
EV/FCF |
— | 50.05 | 50.05 | 50.05 | 43.56 | 45.67 | 29.94 | 17.20 | 15.01 |
Quick Ratio |
— | — | 1.08 | 1.25 | 2.30 | 2.03 | 1.76 | 1.80 | 1.55 |
Current Ratio |
— | — | 1.12 | 1.29 | 2.35 | 2.09 | 1.81 | 1.86 | 1.60 |
Net Debt/EBITDA |
— | 0.00 | (0.40) | (1.90) | 1.34 | 25.10 | (14.33) | (20.25) | (10.87) |
Debt/Assets |
0.00% | — | 0.00% | 9.97% | 4.62% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | — | 0.00 | 0.23 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 4.97 | 1.90 | 1.83 | 1.85 | 1.63 | 1.69 |
Operating CF/Net income |
— | (1.75) | 2.95 | 1.24 | (0.29) | (5.50) | 3.50 | 7.60 | 7.13 |
Capex/Depreciation |
— | 0.00 | (3.25) | (0.19) | (0.21) | (0.02) | (0.02) | 0.00 | 0.00 |
Interest Coverage |
— | 0.67 | 2.32 | 13.24 | (203.21) | 35.28 | (2.47) | — | — |
| — | 0.00% | 6.42% | 24.61% | (63.39%) | (1.77%) | 4.10% | 2.23% | 3.11% | |
| — | 0.00% | 0.00% | 19.00% | (37.08%) | (1.16%) | 2.57% | 1.35% | 1.83% | |
ROIC |
— | — | 0.00% | 17.28% | (84.26%) | (6.99%) | 5.92% | 5.52% | 6.87% |
Return on Tangible Assets |
— | 0.00% | 41.22% | 65.15% | (72.20%) | (2.95%) | 7.30% | 3.72% | 6.68% |
Average Days of Receivables |
— | 0.00 | 35.90 | 44.28 | 44.35 | 51.01 | 64.02 | 66.46 | 68.93 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 8.05% | 6.48% | 6.78% | 28.84% | 11.01% | 8.10% | 8.79% | 7.79% |
Intangible Assets out of Total Assets |
0.00 | — | 0.00 | 0.38 | 0.27 | 0.23 | 0.25 | 0.22 | 0.31 |
Share Based Compensation of Revenue |
— | 0.00% | 0.03% | 0.06% | 26.24% | 4.97% | 2.24% | 3.26% | 3.35% |
Graham Net Nets |
— | 0.00 | 0.00 | 0.00 | 0.08 | 0.11 | 0.11 | 0.16 | 0.11 |
Graham Number |
— | 0.00 | 0.00 | 3.29 | 0.00 | 0.00 | 4.72 | 4.09 | 5.12 |
Earnings Yield |
— | 1.42% | 1.42% | 1.42% | (7.04%) | (0.40%) | 0.80% | 0.66% | 0.76% |
Free Cash Flow Yield |
— | 1.95% | 1.95% | 1.95% | 2.05% | 1.91% | 2.91% | 4.67% | 5.63% |
Revenue per Share |
— | 6.21 | 8.20 | 8.52 | 9.39 | 12.26 | 14.20 | 14.54 | 17.38 |
Operating CF per Share |
— | 0.05 | 0.25 | 0.41 | 0.53 | 0.43 | 0.69 | 0.92 | 1.34 |
Capex per Share |
— | 0.00 | (0.06) | 0.00 | (0.01) | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
— | 0.05 | 0.19 | 0.40 | 0.53 | 0.43 | 0.69 | 0.92 | 1.34 |
Cash per Share |
— | 0.00 | 0.49 | 0.88 | 3.11 | 3.14 | 3.34 | 4.11 | 3.93 |
Shareholders Equity per Share |
— | 0.00 | 0.00 | 1.50 | 4.37 | 4.69 | 5.20 | 5.72 | 6.47 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.00 | 0.00 | 1.50 | 4.37 | 4.69 | 5.20 | 5.72 | 6.47 |
Free Cash Flow |
— | 5.25 | 18.65 | 38.51 | 54.51 | 47.09 | 80.67 | 109.28 | 163.40 |
Working Capital |
— | — | 14.38 | 43.15 | 256.22 | 287.69 | 313.85 | 385.68 | 342.48 |
Capital Expenditures |
— | (0.22) | (5.71) | (0.38) | (0.55) | (0.10) | (0.11) | — | — |
Net Current Asset Value |
— | — | 129.60 | 4.77 | 210.48 | 278.20 | 308.29 | 382.49 | 332.57 |
EV/EBIT |
— | 80.55 | 80.55 | 80.55 | 0.00 | 0.00 | 116.70 | 110.39 | 71.52 |
Capex to Sales |
— | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
— | 82.40 | 82.40 | 82.40 | 0.00 | 0.00 | 134.03 | 137.46 | 84.62 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | 0.00 | 0.31 | 0.41 | 0.58 | 1.55 | 2.81 | 5.85 | 19.66 |
Cash ROIC |
— | 0.00% | 21.53% | 14.75% | 6.79% | 5.43% | 8.09% | 9.30% | 12.86% |
Accounts Receivable Turnover |
— | 0.00 | 8.91 | 9.26 | 8.93 | 8.84 | 6.90 | 5.72 | 5.92 |
Accounts Payable Turnover |
— | 15.12 | 18.03 | 12.04 | 21.18 | 24.73 | 27.04 | 22.31 | 21.40 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | (1.92) | 42.10 | 19.51 | 18.60 | 15.78 | 14.11 | 19.19 | 18.47 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | 88.23 | 88.23 | 108.26 | 153.50 | 240.19 | 303.47 | 358.54 |
Average Payables |
— | 39.82 | 39.82 | 61.02 | 42.62 | 49.41 | 55.33 | 69.91 | 89.40 |
Average Assets |
— | — | 0.00 | 164.48 | 507.67 | 739.59 | 896.36 | 1,067.84 | 1,252.58 |
Average Common Equity |
— | — | 128.48 | 126.93 | 296.92 | 484.62 | 563.22 | 645.42 | 737.20 |
Columns are period end dates